GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nexeon MedSystems Inc (OTCPK:NXNN) » Definitions » Cash Flow from Others

NXNN (Nexeon MedSystems) Cash Flow from Others : $-3.62 Mil (TTM As of Sep. 2018)


View and export this data going back to 2017. Start your Free Trial

What is Nexeon MedSystems Cash Flow from Others?

Nexeon MedSystems's cash flow from others for the three months ended in Sep. 2018 was $0.03 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Sep. 2018 was $-3.62 Mil.


Nexeon MedSystems Cash Flow from Others Historical Data

The historical data trend for Nexeon MedSystems's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nexeon MedSystems Cash Flow from Others Chart

Nexeon MedSystems Annual Data
Trend Dec15 Dec16 Dec17
Cash Flow from Others
- - 0.09

Nexeon MedSystems Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.63 -3.56 0.04 -0.13 0.03

Nexeon MedSystems Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.62 Mil.

Nexeon MedSystems Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Nexeon MedSystems's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Nexeon MedSystems Business Description

Traded in Other Exchanges
N/A
Address
10 Jews Street, Ramsbury Site, Charlestown, MA, USA, 33401
Nexeon MedSystems Inc is a neuromodulation medical device manufacturing company. It is engaged in the development and commercialization of its neurostimulation technology platform for the treatment of disorders related to tissues of the nervous system.
Executives
William Rosellini director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER 2900 N FITZHUGH, SUITE 100, DALLAS TX 75204